Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP238203.RApQNGivWDZRng28HYB4J9e03MQaNnD0cLSIb-sPg-fEc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP238203.RApQNGivWDZRng28HYB4J9e03MQaNnD0cLSIb-sPg-fEc130_assertion type Assertion NP238203.RApQNGivWDZRng28HYB4J9e03MQaNnD0cLSIb-sPg-fEc130_head.
- NP238203.RApQNGivWDZRng28HYB4J9e03MQaNnD0cLSIb-sPg-fEc130_assertion description "[studies are the first to demonstrate a prognostic role of B2M at the mRNA level and suggest that low B2M expression levels might be useful for identifying patients with lymph node metastasis and/or poor survival ]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP238203.RApQNGivWDZRng28HYB4J9e03MQaNnD0cLSIb-sPg-fEc130_provenance.
- NP238203.RApQNGivWDZRng28HYB4J9e03MQaNnD0cLSIb-sPg-fEc130_assertion evidence source_evidence_literature NP238203.RApQNGivWDZRng28HYB4J9e03MQaNnD0cLSIb-sPg-fEc130_provenance.
- NP238203.RApQNGivWDZRng28HYB4J9e03MQaNnD0cLSIb-sPg-fEc130_assertion SIO_000772 18506145 NP238203.RApQNGivWDZRng28HYB4J9e03MQaNnD0cLSIb-sPg-fEc130_provenance.
- NP238203.RApQNGivWDZRng28HYB4J9e03MQaNnD0cLSIb-sPg-fEc130_assertion wasDerivedFrom lhgdn-20090331 NP238203.RApQNGivWDZRng28HYB4J9e03MQaNnD0cLSIb-sPg-fEc130_provenance.
- NP238203.RApQNGivWDZRng28HYB4J9e03MQaNnD0cLSIb-sPg-fEc130_assertion wasGeneratedBy ECO_0000203 NP238203.RApQNGivWDZRng28HYB4J9e03MQaNnD0cLSIb-sPg-fEc130_provenance.